ãã€ãªå»è¬åäŒæ¥ã§ãã Puma Biotechnology, Inc. ã¯ãç±³åœããã³åœéçã«ããæ²»çã匷åãã補åã®éçºãšåååã«æ³šåããŠããŸããå瀟ã®åè£è¬ã«ã¯ãæ©ææ®µéã® HER2 éå°çºçŸ/å¢å¹
ä¹³ããã®æäººæ£è
ã®è£å©çæ³çšã® PB272 ãã©ããã (çµå£å€)ãé²è¡æ§ãŸãã¯è»¢ç§»æ§ HER2 éœæ§ä¹³ããã®æäººæ£è
ã®æ²»çã«ãã©ããããšã«ãã·ã¿ãã³ã®äœµçšã§äœ¿çšãã PB272 (ãã©ããããçµå£å€)ãHER2 å€ç°éœæ§åºåœ¢è
«ççšã® PB272 (ãã©ããããçµå£å€) ãªã©ããããŸããå瀟㯠Pfizer, Inc. ãšã©ã€ã»ã³ã¹å¥çŽãçµãã§ããŸãããŸããSpecialised Therapeutics Asia Pte Ltd.ãCANbridge BIOMED LimitedãPint Pharma International SAãKnight Therapeutics, Inc.ãPierre Fabre Medicament SASãBixink Therapeutics Co., Ltd.ãšãµãã©ã€ã»ã³ã¹å¥çŽãç· çµããŠããŸããå瀟ã¯2010幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ããµã³ãŒã«ã¹ã«æ¬ç€Ÿã眮ããŠããŸãã